Christine S. Muli

Christine S. Muli's work spans biochemistry and drug discovery, including studies of protein degradation pathways (like the ubiquitin-proteasome system, which cells use to break down unwanted proteins), structural biology methods such as NMR and crystallography, and the design of small-molecule inhibitors targeting cancer-related proteins like RAF kinases. Recent publications also touch on synthetic chemistry, such as sugar-based surfactant molecules. This research combines chemical synthesis, structural analysis, and biological testing to understand and potentially treat disease-related protein malfunctions, particularly in cancer.

Publication output has grown notably in recent years, rising from occasional single papers in 2017-2020 to a higher and increasing yearly count from 2023 through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026